|
2022
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases, infec... |
|
2021
|
Invention
|
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using... |
|
2019
|
Invention
|
Method for treating intestinal diseases presenting at least one inflammatory component.
The pres... |
|
|
Invention
|
Antibody formulations.
Formulations of anti-VLA-1 antibodies are described. |
|
2018
|
Invention
|
Anti-vla1 (cd49a) antibody pharmaceutical compositions.
Formulations of anti-VLA-1 antibodies ar... |
|
|
Invention
|
Controlled-release solid dosage forms of mesalamine. Described are controlled-release solid dosag... |
|
2016
|
Invention
|
Selection and treatment of subjects.
The invention relates to methods of selecting a subject, an... |
|
2015
|
Invention
|
Treatment of hereditary angioedema with c1 inhibitor. A method for treating acute attacks of here... |
|
2014
|
Invention
|
Novel formulations of proton pump inhibitors and methods of using these formulations.
The presen... |
|
|
Invention
|
Pharmaceutical formulation and method for treating acid caused gastrointestinal disorders.
Pharm... |
|
2013
|
Invention
|
Anti-vla1 (cd49a) antibody pharmaceutical compositions. Formulations of anti-VLA-1 antibodies are... |
|
|
Invention
|
Antibody formulations. Formulations of anti-VLA-1 antibodies are described. |
|
|
Invention
|
Method for treating intestinal diseases presenting at least one inflammatory component. The prese... |
|
2012
|
Invention
|
Selection and treatment of subjects. The invention relates to methods of selecting a subject, and... |
|
2010
|
Invention
|
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders.
Pharm... |
|
2009
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases, infect... |
|
2008
|
P/S
|
Pharmaceutical products, namely, lipid and triglyceride reducing agents |
|
|
P/S
|
Pharmaceutical preparations for the treatment of gastrointestinal problems and diseases |
|
2007
|
Invention
|
Novel formulations of proton pump inhibitors and methods of using these formulations. The present... |
|
|
Invention
|
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers.
Pharmaceutical c... |
|
2005
|
Invention
|
Pharmaceutical formulations useful for inhibiting acid secretion. The present invention rel... |
|
|
Invention
|
Pharmaceutical formulations useful for inhibiting acid secretion. The present invention relates t... |
|
|
Invention
|
Combination of proton pump inhibitor, buffering agent, and prokinetic agent. Pharmaceutical... |
|
|
Invention
|
Combination of proton pump inhibitor, buffering agent, and prokinetic agent. Pharmaceutical compo... |
|
|
Invention
|
Combination of proton pump inhibitor, buffering agent, and prokinetic agent.
Pharmaceutical comp... |
|
|
Invention
|
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppres... |
|
|
Invention
|
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug.
... |
|
|
Invention
|
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent. ... |
|
2004
|
P/S
|
Pharmaceutical preparations for the treatment of gastrointestinal problems and diseases. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of gastroinstestinal problems and diseases |
|
|
Invention
|
Combination of proton pump inhibitor and sleep aid.
Pharmaceutical compositions comprising a pro... |
|
|
P/S
|
Chemicals used in industry, and science; chemicals used in the pharmaceutical industry. Pharmaceu... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of gastro-intestinal problems and diseases; except ... |
